Message :
Required fields
BOSTON, May 13, 2021 /PRNewswire/ Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2021, which ended April 3, 2021, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 13, 2021. The conference call and webcast can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 8694785
A live webcast of the call can be accessed on Haemonetics Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/xqyzme3t
Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
Financial release accessible online
Share this article
Share this article
BOSTON, May 13, 2021 /PRNewswire/ Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2021, which ended April 3, 2021, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 13, 2021. The conference call and webcast can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 8694785
Share this article
Share this article
BOSTON, April 29, 2021 /PRNewswire/ Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that the full peer-reviewed results of the IMproving PlasmA CollecTion (IMPACT) trial have been published in TRANSFUSION, the prime journal for transfusion medicine related research. The publication expands upon the IMPACT trial data presented in October 2020 in a plenary session at the AABB conference. IMPACT, a multicenter, prospective and double-blinded study, is one of the largest randomized controlled trials of plasmapheresis. The trial involved 3,443 donors who underwent 23,137 plasma donations.
Share this article
Share this article
BOSTON, April 23, 2021 /PRNewswire/ Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish fourth quarter and fiscal year 2021 financial results at 6:00 am EDT on Thursday, May 13, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on May 13, 2021.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 8694785
A live webcast of the call can be accessed on Haemonetics investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/xqyzme3t
Haemonetics Provides Update On U S Plasma Business prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.